All HSCTs resulted in successful engraftment and immune reconstitution, except for one child with reticular dysgenesis associated with an AK2 gene variant, who underwent unrelated donor HSCT at 3 months 2 weeks but died on day 12 post-transplant due to infectious complications. The gene discussed is AK2; the disease is reticular dysgenesis.